Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 709-713

  Bristow, Robert E ^a   Purinton, Scott C ^a   Santillan, Antonio ^a   Diaz Montes, Teresa P ^a   Gardner, Ginger J ^a   Giuntoli II, Robert L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cost effectiveness; Endometrial cancer; Surveillance

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DATA ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; HUMAN; MEDICAL RECORD; PAPANICOLAOU TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

COST-BENEFIT ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; HEALTH CARE COSTS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; VAGINAL SMEARS;

EID: 33750158302     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.05.013     Document Type: Article

References (18)

1. American Cancer Society. Cancer Facts and Figures. 2006. Atlanta: American Cancer Society; 2006. Available from: http://www.cancer.org/docroot/STT/stt_0.asp.
2. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics 2005. CA Cancer J Clin 55 (2005) 10-30
3. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
4. Tjalma W.A.A., van Dam P.A., Makar A.P., and Cruickshanks D.J. The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Int J Gynecol Cancer 14 (2004) 931-937
5. Barnhill D., O'Connor D., Farley J., Teneriello M., Armstrong D., and Park R. Clinical surveillance of gynecologic cancer patients. Gynecol Oncol 46 (1992) 275-280
6. Morice P., Levy-Piedbois C., Ajaj S., Pautier P., Haie-Meder C., Lhomme C., et al. Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer 37 (2001) 985-990
7. Gadducci A., Cosio S., Fanucchi A., Cristofani R., and Genazzani A.R. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Anticancer Res 20 (2000) 1977-1984
8. Ng T.Y., Ngan H.Y., Cheng D.K., and Wong L.C. Vaginal vault cytology in the routine follow-up of patients treated for endometrial carcinoma: is it useful?. Aust N Z J Obstet Gynaecol 37 (1997) 104-106
9. Kew F.M., Roberts A.P., and Cruickshank D.J. The role of routine follow-up after gynecologic malignancy. Int J Gynecol Cancer 15 (2005) 413-419
10. Podczaski E., Kaminski P., Gurski K., MacNeill C., Stryker J.A., Singapuri K., et al. Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol 47 (1992) 323-327
11. Shumsky A.G., Stuart G.C.E., Brasher P.M., Nation J.G., Robertson D.I., and Sangkarat S. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 55 (1994) 229-233
12. Owen P., and Duncan I.D. Is there any value in the long-term follow-up of women treated for endometrial cancer?. Br J Obstet Gynaecol 103 (1996) 710-713
13. Agboola O.O., Grunfeld E., Coyle D., and Perry G.A. Costs and benefits of routine follow-up after curative treatment for endometrial cancer. Can Med Assoc J 157 (1997) 879-886
14. Salvesen H.B., Akslen L.A., Iversen T., and Iversen O.E. Recurrence of endometrial carcinoma and the value of routine follow-up. Br J Obstet Gynaecol 104 (1997) 1302-1307
15. Berchuck A., Anspach C., Evans A.C., Soper J.T., Rodriguez G.C., Dodge R., et al. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol 59 (1995) 20-24
16. Reddoch J.M., Burke T.W., Morris M., Tornos C., Levenback C., and Gershenson D.M. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol 59 (1995) 221-225
17. Cooper A.L., Dornfeld-Finke J.M., Banks H.W., Davey D.D., and Modesitt S.C. Is cytologic screening and effective method of surveillance to detect vaginal recurrence of uterine cancer?. Obstet Gynecol 107 (2006) 71-76
18. Gordon A.F., Owen P., Chien P.F., and Duncan I.D. A critical evaluation of follow-up of women treated for endometrial adenocarcinoma. J Obstet Gynaecol 17 (1997) 386-389